Hawthorn Crataegus Extract, Blood Pressure and Heart Function Multi-Target 2025 Meta-Analysis
WELLNESS

Hawthorn Crataegus Extract, Blood Pressure and Heart Function Multi-Target 2025 Meta-Analysis

By Sophie · · Phytomedicine 2025
KO | EN

Hawthorn (Crataegus) standardized extract 600~1,800 mg/day 8~16 weeks reduced systolic BP -8mmHg and improved chronic heart failure NYHA grade per 17 RCT 1,400 participant 2025 meta-analysis. European 600+ year traditional cardiovascular plant clinical evidence.

Phytomedicine 2025 meta-analysis integrated 17 RCTs 1,400 participants of hawthorn extract. Standardized extract (oligomeric procyanidin OPC 18.75% + flavonoids 2.2%) 600~1,800 mg/day 8~16 weeks: systolic BP average -8mmHg, diastolic -5mmHg, chronic heart failure NYHA II~III exercise tolerance + dyspnea meaningfully improved.

What is Hawthorn

Hawthorn (Crataegus monogyna, C. laevigata) is a Rosaceae shrub/small tree. English “Hawthorn,” German “Weißdorn.” Native to Europe + East Asia. Korean Sansa-ja (山査子, C. pinnatifida) is herb + dietary staple.

Active components:

  • Oligomeric procyanidin (OPC): Polyphenol, antioxidant + vascular support
  • Flavonoids: Vitexin, vitexin-2”-O-rhamnoside, quercetin
  • Triterpenoid acids: Ursolic acid, oleanolic acid
  • Catechins: Antioxidant

European 600+ year tradition (German Commission E approved), Korean traditional medicine sansa-ja 1,000+ year.

Multi-Target Mechanism

1. Vasodilation + BP reduction: NO (nitric oxide) synthesis support + partial ACE enzyme inhibition. Gentle vasodilation 2. Cardiac contractility support: Positive inotropic effect. Different mechanism from digoxin. cAMP increase 3. Antiarrhythmic: Atrial fibrillation/ventricular arrhythmia frequency reduction (some clinical) 4. Antioxidant: OPC prevents LDL oxidation + atherosclerosis support 5. Anti-inflammatory: NF-κB inhibition 6. Myocardial protection: Ischemia/reperfusion injury support (preclinical)

Clinical Data

  • Phytomedicine 2025 meta-analysis 17 trials 1,400: SBP -8mmHg, DBP -5mmHg
  • SPICE Trial 2008 (landmark): Chronic heart failure 2,681 patients, mortality not significant, symptoms meaningfully improved
  • Meta-analysis 14 (2023): NYHA II~III exercise tolerance consistent improvement
  • Germany clinical 2024 RCT 80 8 weeks: Mild hypertension SBP -10mmHg, side effects minimal

Korean Sansa-ja Diet

Korean sansa-ja (山査子, Crataegus pinnatifida):

  • Hawthorn berry, autumn harvest
  • Sansa tea: 5~10g dried slices + boiling water
  • Sansa porridge: Some traditional medicine recipes
  • Bohwahwan (保和丸) and other formula ingredient
  • Some Korean desserts + beverages

Source: Traditional medicine shops/online. 100g 5,000~12,000 won.

Supplement Options

  • Standardized extract (WS 1442) capsule 300~450 mg twice daily 30,000~70,000 won
  • Sansa powder/tea form
  • Liquid extract

Cautions

  • Heart failure drugs (digoxin, ACE inhibitor, beta blocker) combination: Synergy possible, physician evaluation essential
  • BP drug combination: Hypotension risk, physician evaluation
  • Anticoagulants (warfarin): Mild antiplatelet, physician evaluation
  • Pregnancy/lactation: Insufficient safety data, avoid
  • Stop 2 weeks before surgery
  • Some report mild dizziness (BP reduction), GI discomfort

Synergy Matrix

  • Olive leaf: BP matrix
  • Bergamot polyphenol: LDL synergy
  • CoQ10: Cardiac mitochondria
  • Magnesium: Arrhythmia + BP dual
  • Omega-3 EPA: Cardiovascular matrix

Consumer Message

Cardiovascular drugs (statins, ACE inhibitors, beta blockers) are standard, but hawthorn meaningful for mild hypertension/functional cardiovascular support. Korean sansa-ja’s 1,000+ year tradition makes it familiar. However, heart failure/cardiovascular drug users require physician evaluation, never self-prescribe. Diet (vegetables, fruits, fish) + exercise + sleep foundation. Spring 2026 natural cardiovascular option.